CARG vs GSK · P/E 94, rev $494.5M vs P/E 13, $103.31B cap
CarGurus (CARG) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
CarGurus (CARG) is a auto & truck dealerships company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported CARG revenue for 2026-06-30 was $494.5M. Net income was $81.4M. CARG currently screens at market cap $3.43B and trailing P/E 93.7.
GSK does not have a complete income-statement cache yet.
CARG currently screens at market cap $3.43B and trailing P/E 93.7. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the CARG and GSK stock pages for the full models.
Not investment advice.